Among those women receiving additional interventions (twelve in the misoprostol group; nineteen in the placebo group), total measured blood loss was significantly higher (940 ± 341 ml, p = .028) compared with women (n = 29) who did not receive any additional intervention beyond standard treatment (780 ± 176 ml).
600 mcg sublingual misoprostol
placebo in addition to standard PPH treatment with injectable oxytocics
Total blood loss